Suzan Muratoglu Severcan
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Suzan Muratoglu Severcan has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Cinar Severcan
Department of Biochemistry , Zonguldak Bulent Ecevit University Faculty of Pharmacy , Zonguldak , Türkiye
2 shared publications - Aslıhan Gürbüz
Medical Faculty of Ankara University
1 shared publication - Gülce Kiren
Department of Medical Biochemistry, Ministry of Health Sincan Training and Research Hospital, Ankara 06949, Türkiye
1 shared publication - Hatice Paşaoğlu
Gazi University Faculty of Medicine, Department of Medical Biochemistry, Ankara, Türkiye
1 shared publication - Mostafa Norizadeh Tazehkand
Department of Biotechnology, Faculty of Advanced Sciences and Technology, Tehran Medical Sciences, Islamic Azad University, Tehran, Iran
1 shared publication - Zehra Safi Oz
Department of Medical Biology, Faculty of Medicine, Zonguldak Bulent Ecevit University, 67600 Zonguldak, Türkiye
1 shared publication
Latest Publications
- Open Access
- 14 June 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (4) , 518-524
The effect of curcumin on PI3K/Akt and AMPK pathways in insulin resistance induced by fructose
Objectives: Excessive fructose consumption is recognized to elevate insulin resistance in animals and humans. In our study, we aimed to assess the possible consequences of curcumin (curc) treatment applied to rat models of fructose-induced insulin resistance on adenosine monophosphate-activated protein kinase (AMPK) and phosphatidylinositol-3 kinase (PI3K)/protein kinase B (Akt) pathways in skeletal muscle and adipose tissue. Methods: We established four distinct rat groups: corn oil (negative control group), 20 % fructose (positive control group), 20 % fructose and 100 mg/kg curc (100 mg/kg curc group), and 20 % fructose and 200 mg/kg curc (200 mg/kg curc group). The ELISA method was used to determine serum insulin levels, an auto-analyzer was used to measure serum glucose levels, and homeostatic model assessment of insulin resistance (HOMA-IR) values were calculated. In the rat’s skeletal muscle and adipose tissues, the ELISA method was used to determine the following parameters: insulin receptor substrate-1 (IRS-1), phosphorylated insulin receptor substrate-1 (p-IRS-1), PI3K, phosphatidylinositol 3,4,5-trisphosphate (PIP3), phosphoinositide-dependent kinases (PDK-1), phosphorylated Akt (p-Akt), AMPK and glucose transporter type 4 (GLUT4) levels. Results: The positive control group exhibited a significant increase in serum glucose, insulin, and HOMA-IR levels, confirming the establishment of the insulin resistance model. In the curcumin dose groups, these values significantly decreased. Additionally, compared to the positive control groups, curcumin dose groups demonstrated a significant increase in the parameters of the Akt/PI3K pathway, AMPK activation, and GLUT4 levels in skeletal muscle and adipose tissues. Conclusions: We observed that curcumin demonstrates potential ameliorative effects on the insulin signaling pathway through PI3K/Akt and AMPK pathways.
- 14 June 2024
- Published by Walter de Gruyter GmbH in Turkish Journal of Biochemistry
- Vol. 49 (4) , 518-524
Open AccessThe effect of curcumin on PI3K/Akt and AMPK pathways in insulin resistance induced by fructose
Objectives: Excessive fructose consumption is recognized to elevate insulin resistance in animals and humans. In our study, we aimed to assess the possible consequences of curcumin (curc) treatment applied to rat models of fructose-induced insulin resistance on adenosine monophosphate-activated protein kinase (AMPK) and phosphatidylinositol-3 kinase (PI3K)/protein kinase B (Akt) pathways in skeletal muscle and adipose tissue. Methods: We established four distinct rat groups: corn oil (negative control group), 20 % fructose (positive control group), 20 % fructose and 100 mg/kg curc (100 mg/kg curc group), and 20 % fructose and 200 mg/kg curc (200 mg/kg curc group). The ELISA method was used to determine serum insulin levels, an auto-analyzer was used to measure serum glucose levels, and homeostatic model assessment of insulin resistance (HOMA-IR) values were calculated. In the rat’s skeletal muscle and adipose tissues, the ELISA method was used to determine the following parameters: insulin receptor substrate-1 (IRS-1), phosphorylated insulin receptor substrate-1 (p-IRS-1), PI3K, phosphatidylinositol 3,4,5-trisphosphate (PIP3), phosphoinositide-dependent kinases (PDK-1), phosphorylated Akt (p-Akt), AMPK and glucose transporter type 4 (GLUT4) levels. Results: The positive control group exhibited a significant increase in serum glucose, insulin, and HOMA-IR levels, confirming the establishment of the insulin resistance model. In the curcumin dose groups, these values significantly decreased. Additionally, compared to the positive control groups, curcumin dose groups demonstrated a significant increase in the parameters of the Akt/PI3K pathway, AMPK activation, and GLUT4 levels in skeletal muscle and adipose tissues. Conclusions: We observed that curcumin demonstrates potential ameliorative effects on the insulin signaling pathway through PI3K/Akt and AMPK pathways.
- Open Access
- 31 March 2021
- Published by Hitit University in Hittite Journal of Science and Engineering
- Vol. 8 (1) , 79-83
Evaluation of Oxidant-Antioxidant Status of Fluvoxamine on Human Lymphocyte Cell Culture
Depression is one of the prevalent psychiatric diseases in Turkey and the world. Fluvoxamine is a strong selective serotonin reuptake inhibitor (SSRI) that is used as an antidepressant. No study investigating the doses of Fluvoxamine treatment that may lead to a disruption in the oxidant-antioxidant balance on the cellular level in addition to its beneficial effects has been found in the literature. For this purpose, by creating Fluvoxamine application groups at the doses of 7.5, 15, 30 and 60 μM and durations of 24 and 48 hours on human lymphocyte cell cultures, we investigated the total oxidant status (TOS), total antioxidant status (TAS) and oxidative stress index (OSI). According to the results of the study, the TOS levels of all dose groups increased significantly in the 24- and 48-hour applications (p<0.05). While the TAS levels significantly increased in the 24-hour application of the doses of 7.5 and 15 μM and 48-application of the dose of 7.5 μM, they significantly decreased in the 24- and 48-hour applications of the doses of 30 and 60 μM (p<0.05). The OSI level increased significantly in the 24- and 48-hour applications of the doses of 30 and 60 μM. The results of our study demonstrated that, in the 24- and 48-hour applications of the doses of 30 and 60 μM, the antioxidant system could not compensate and the cells exposed to oxidative stress.
- 31 March 2021
- Published by Hitit University in Hittite Journal of Science and Engineering
- Vol. 8 (1) , 79-83
Open AccessEvaluation of Oxidant-Antioxidant Status of Fluvoxamine on Human Lymphocyte Cell Culture
Depression is one of the prevalent psychiatric diseases in Turkey and the world. Fluvoxamine is a strong selective serotonin reuptake inhibitor (SSRI) that is used as an antidepressant. No study investigating the doses of Fluvoxamine treatment that may lead to a disruption in the oxidant-antioxidant balance on the cellular level in addition to its beneficial effects has been found in the literature. For this purpose, by creating Fluvoxamine application groups at the doses of 7.5, 15, 30 and 60 μM and durations of 24 and 48 hours on human lymphocyte cell cultures, we investigated the total oxidant status (TOS), total antioxidant status (TAS) and oxidative stress index (OSI). According to the results of the study, the TOS levels of all dose groups increased significantly in the 24- and 48-hour applications (p<0.05). While the TAS levels significantly increased in the 24-hour application of the doses of 7.5 and 15 μM and 48-application of the dose of 7.5 μM, they significantly decreased in the 24- and 48-hour applications of the doses of 30 and 60 μM (p<0.05). The OSI level increased significantly in the 24- and 48-hour applications of the doses of 30 and 60 μM. The results of our study demonstrated that, in the 24- and 48-hour applications of the doses of 30 and 60 μM, the antioxidant system could not compensate and the cells exposed to oxidative stress.